Prudential plc · PUK · FY2026 Q2 · Calendar Q3 2026
Prudential sustains growth and capital returns focus in H1 2026
The supplied analysis supports a constructive but conditional view: H1 growth, Hong Kong margin expansion, Asian distribution strength, and planned capital returns support the operating case, while regulatory changes, agency execution, IFRS 17 volatility, and the potential Bharti transaction are material offsets.
Earnings scorecard
Reported versus consensusMarket reaction
close-to-close (session unavailable)Ask FN2 about PUK FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the supplied analysis moved from a broad double-digit-growth objective to H1 evidence of 8% new business profit growth, 17% EPS growth, and 15% higher free surplus generation. It also adds a PRUAction 1.0 rollout in Singapore, a planned free-float proceeds contribution, and potential Bharti Life acquisition activity.
Guidance delta
Management maintained its 2026 guidance; the supplied analysis does not provide a revised numerical outlook.
Key takeaways
- H1 2026 new business profit rose 8%, EPS rose 17%, and free surplus generation increased 15%.
- Hong Kong margin expanded by 7 percentage points, supported by health and protection products and bancassurance.
- Management is progressing its capability investment, AI rollout, and quality agency recruitment agenda.
- Capital returns include a $1.2 billion buyback and a plan to return more than $7 billion by 2027.
- India expansion includes the HCL health joint venture and potential acquisition of the Bharti Life platform.
Management priorities
- Complete the $300-$350 million capability investment program in 2026
- Scale the PRUAction AI module beyond Singapore
- Expand health, protection, and affluent propositions across ASEAN
- Finalize and integrate the Bharti Life platform if acquired
- Continue agency transformation and the shareholder-return program
Follow PUK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Buy | Maintain | Feb 14, 2022 |
| HSBC | Buy | Hold | Upgrade | Mar 23, 2021 |
| Macquarie | Outperform | Outperform | Maintain | Oct 3, 2019 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 10, 2018 |
| JP Morgan | Neutral | Underweight | Upgrade | Mar 17, 2017 |
| Societe Generale | Sell | Hold | Downgrade | Oct 13, 2016 |
| Jefferies | Hold | Buy | Downgrade | Jul 20, 2015 |
| Charles Stanley | Buy | Accumulate | Maintain | Jun 10, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $26.09. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Berenberg Bank | Michael Huttner | $39.3 | $27.29 | +50.6% | Sep 3, 2026 |
Track every rating change on PUK the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPrudential plc, operating through its various subsidiaries, delivers a diverse array of financial solutions to individuals across Asia and Africa, encompassing life and health coverage, retirement planning, and comprehensive asset management services. Its product portfolio includes extensive health and protection plans, along with various savings instruments such as participating, unit-linked, and conventional policies.…
Financial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
| HIG The Hartford Insurance Group, Inc. | FY2026 Q2 · Calendar Q3 2026 | +8.2% | -1.2% | The Hartford Beats on Q2 Core Earnings, Divests Hartford Funds, Expands Buyback to $4.2B |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the PUK recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-27T16:21:08.103648+00:00
- FN2 earnings calendar · 2026-09-21T01:23:13.071796+00:00
- Polygon adjusted daily market bars · 2026-09-21T05:20:50.026536+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T05:20:50.023561+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.